<DOC>
	<DOCNO>NCT01151345</DOCNO>
	<brief_summary>This study research existance actual bioequivalence Diltiazem 60 Mg Tablets As Tilazem 60® Made Pfizer , S.A. DE C.V. , Versus Angiotrofin® 60 Mg Made Amstrong Laboratorios De Mexico , S.A. DE C.V .</brief_summary>
	<brief_title>Bioequivalence Study Of Diltiazem In 60 Mg Tablets As Tilazem 60® Made Pfizer , S.A. De C.V. , Versus Angiotrofin® 60 Mg Made Amstrong Laboratorios De Mexico , S.A. De C.V .</brief_title>
	<detailed_description>Bioequivalence particular drug</detailed_description>
	<mesh_term>Diltiazem</mesh_term>
	<mesh_term>Kallikreins</mesh_term>
	<criteria>Healthy male and/or female subject age 18 55 year , inclusive ( Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12lead ECG clinical laboratory test ) . Both gender Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ± 10 % variation ideal weight ; total body weight &gt; 50 kg ( 110 lb ) . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . Any condition possibly affect drug absorption ( eg , gastrectomy ) . A positive urine drug screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>diltiazem</keyword>
	<keyword>angiotrofin</keyword>
	<keyword>bioequivalence</keyword>
</DOC>